Antidepressant drugs may not improve long-term quality of life
A new study has revealed that antidepressant drugs may not be an effective long-term solution for people with depression disorder, identifying that they may...
Researchers identify promising drugs for Crimean-Congo haemorrhagic fever
New research has identified key signalling pathways that, when blocked by existing drug candidates, limit the reproduction of the Crimean-Congo haemorrhagic fever virus.
Crimean-Congo haemorrhagic...
Improving the survival rate for bladder cancer with nintedanib
New research discovered that adding nintedanib, a targeted cancer growth inhibitor, to chemotherapy could improve the survival rate for bladder cancer.
Nintedanib is a targeted...
Valneva COVID-19 vaccine approved by MHRA
Medicines and Healthcare products Regulatory Agency (MHRA) have approved a new COVID-19 vaccine by Valneva for use in the UK.
Valneva, a speciality vaccine company,...
Cervical cancer vaccine to eliminate the disease worldwide
A research team from the University of Washington’s School of Medicine has noted that successful administration of the cervical cancer vaccine could potentially eliminate...
NICE announces two new antimicrobial drugs coming to the NHS
Cefiderocol and ceftazidime-avibactam, two antimicrobial drugs, will be made available on the NHS with the hopes to tackle antimicrobial resistance.
The National Institute for Health...
Psilocybin treatment offers effective alternative for patients with depression
Novel research has signified the exciting potential of employing psychedelics to treat depression, finding that psilocybin treatment can help alleviate the impacts of the...
Scientists identify a range of new bladder cancer treatments
A study performed at MedUni Vienna has discovered hundreds of new potential bladder cancer treatments, with one commonly used drug demonstrating effectiveness against two...
Novel antiviral treatment for COVID-19 administered to high-risk patients
The NHS is administering a novel antiviral treatment for COVID-19 to patients who are most at risk, which improves symptoms within hours.
Thousands of patients...
New treatment for urothelial cancer available on the NHS
Over 800 people with locally advanced or metastatic urothelial cancer will benefit from a new treatment – avelumab.
Urothelial cancer is a type of bladder...
Steroid injections provide relief for arthritis patients
A new study finds steroid injections can provide effective pain relief for patients with arthritis in their hip.
Steroid injections are anti-inflammatory medicines that treat...
Predicting cancer drug combinations with AI test
Scientists have created a prototype test that can predict which cancer drug combinations are likely to work for patients in less than two days.
The...
Additional COVID-19 vaccine booster offered in the US
Pfizer announced on 29 March 2022 that the FDA in the US has expanded the emergency utilisation of their vaccine to include an additional...
Groundbreaking treatment for COPD, asthma, and cystic fibrosis
Scientists have developed a revolutionary new treatment for COPD, asthma, and cystic fibrosis that mitigates the potentially deadly symptoms of the conditions.
The novel drug,...
Male contraceptive pill could be on the market soon
Scientists have potentially achieved a significant milestone towards developing a male contraceptive pill, a major advancement for birth control for men.
Pioneered by researchers at...
New lung cancer drug fast-tracked by the NHS
The NHS is fast-tracking a new lung cancer drug for eligible patients that will target an aggressive and rare form of cancer.
Patients in England...
First-ever Creutzfeldt-Jakob disease treatment shows encouraging results
Early study results have highlighted the promising performance of the world’s first treatment for Creutzfeldt-Jakob disease, potentially a landmark step toward treating the deadly...
Life-extending injection for multiple myeloma available on the NHS
The NHS has announced that a life-extending injection for multiple myeloma, a bone marrow cancer, will be available to 350 patients per year in...
Improving the effectiveness of the tuberculosis vaccine
Researchers have found a new way to enhance the tuberculosis vaccine by adding an antibody that can improve long-term effectiveness.
Tuberculosis is a bacterial infection...
Molnupiravir recommended by WHO to reduce COVID-19 hospitalisations
The World Health Organization (WHO) has expressed that the molnupiravir antiviral medication should be administered to patients with non-severe COVID-19 who are at an...
